Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Idec Zevalin May Need Central Monitoring Of Bio-Images, FDA Cmte. Suggests

Sep 24 2001

• By The Pink Sheet

Related Content

Idec Zevalin Clears Cmte.: Non-Refractory Use May Be Accelerated Approval

Sep 17 2001

Idec, GSK, Corixa Discussing Licensing Of Radioimmunotherapy Patents

Sep 24 2001

Idec Zevalin

May 14 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window